Trials / Completed
CompletedNCT00163592
Post-Marketing Surveillance of TISSUCOL for Hemostasis in Subjects Undergoing Vascular Reconstruction With Polytetrafluoroethylene (PTFE) Prosthesis
Non- Interventional Study of Tissucol® for Hemostasis in Subjects With Femoral Vascular Anastomosis Undergoing Vascular Reconstruction With PTFE Prosthesis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (planned)
- Sponsor
- Baxter Healthcare Corporation · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
This study investigates if the time to hemostasis can be reduced by application of Tissucol® onto femoral vascular anastomoses with PTFE prostheses compared to standard methods, such as compression with swabs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tissucol® | |
| PROCEDURE | Control: Conventional treatment, i.e. compression with swabs |
Timeline
- Start date
- 2003-09-01
- Completion
- 2004-02-01
- First posted
- 2005-09-14
- Last updated
- 2006-10-23
Locations
5 sites across 2 countries: Austria, Germany
Source: ClinicalTrials.gov record NCT00163592. Inclusion in this directory is not an endorsement.